These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7811013)

  • 1. Ticarcillin-clavulanic acid pharmacokinetics in preterm neonates with presumed sepsis.
    Burstein AH; Wyble LE; Gal P; Diaz PR; Ransom JL; Carlos RQ; Forrest A
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2024-8. PubMed ID: 7811013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ticarcillin and clavulanic acid given in combination to adult horses by intravenous and intramuscular routes.
    Sweeney RW; Beech J; Simmons RD; Soma LR
    J Vet Pharmacol Ther; 1988 Mar; 11(1):103-8. PubMed ID: 3379659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenously and intramuscularly administered ticarcillin and clavulanic acid in foals.
    Sweeney RW; Beech J; Simmons RD
    Am J Vet Res; 1988 Jan; 49(1):23-6. PubMed ID: 3354961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.
    Reed MD
    Ann Pharmacother; 1998 Jan; 32(1):S17-21. PubMed ID: 9475835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-based ticarcillin/clavulanic acid dose recommendations for infants and children.
    Reed MD; Yamashita TS; Blumer JL
    J Clin Pharmacol; 1995 Jul; 35(7):658-65. PubMed ID: 7560245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis.
    Syrogiannopoulos GA; Al-Sabbagh A; Olsen KD; McCracken GH
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1296-300. PubMed ID: 3314696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of amoxycillin, ticarcillin and clavulanic acid into lymph after intravenous infusion in rabbits to simulate human serum pharmacokinetics.
    Woodnutt G; Berry V; Kernutt I; Mizen L
    J Antimicrob Chemother; 1990 Nov; 26(5):695-704. PubMed ID: 2079451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of ticarcillin/clavulanate acid in neonates.
    Fricke G; Doerck M; Hafner D; Horton R; Kresken M
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():111-20. PubMed ID: 2606813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis.
    Jacobs RF; Trang JM; Kearns GL; Warren RH; Brown AL; Underwood FL; Kluza RB
    J Pediatr; 1985 Jun; 106(6):1001-7. PubMed ID: 3998937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
    Van der Auwera P; Duchateau V; Lambert C; Husson M; Kinzig M; Sörgel F
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1860-8. PubMed ID: 8239597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals.
    Woodnutt G; Kernutt I; Mizen L
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1826-30. PubMed ID: 3501702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis.
    Mizen L; Woodnutt G; Kernutt I; Catherall EJ
    Antimicrob Agents Chemother; 1989 May; 33(5):693-9. PubMed ID: 2665641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels and pharmacokinetics of ticarcillin and clavulanic acid in dog following parenteral administration of Timentin.
    Garg RC; Keefe TJ; Vig MM
    J Vet Pharmacol Ther; 1987 Dec; 10(4):324-30. PubMed ID: 3501810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the biliary excretion of a ticarcillin-clavulanic acid combination in man].
    Brogard JM; Blickle JF; Jehl F; Adloff M; Monteil H
    Pathol Biol (Paris); 1988 May; 36(5):500-6. PubMed ID: 3043347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short versus long infusion of meropenem in very-low-birth-weight neonates.
    Padari H; Metsvaht T; Kõrgvee LT; Germovsek E; Ilmoja ML; Kipper K; Herodes K; Standing JF; Oselin K; Lutsar I
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4760-4. PubMed ID: 22733063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prophylactic use of ticarcillin/clavulanate in the neonate.
    Fayed SB; Sutton AM; Turner TL; McAllister TA
    J Antimicrob Chemother; 1987 Jan; 19(1):113-8. PubMed ID: 3558165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic studies on clavulanate potentiated ticarcillin in normal subjects and patients with renal insufficiency.
    Koeppe P; Höffler D; Hulla FW
    Arzneimittelforschung; 1987 Feb; 37(2):203-8. PubMed ID: 3580024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ticarcillin-clavulanate in premature infants.
    Watt KM; Hornik CP; Balevic SJ; Mundakel G; Cotten CM; Harper B; Benjamin DK; Anand R; Laughon M; Smith PB; Cohen-Wolkowiez M;
    Br J Clin Pharmacol; 2019 May; 85(5):1021-1027. PubMed ID: 30710387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of ticarcillin, clavulanic acid and their combination.
    Höffken G; Tetzel H; Koeppe P; Lode H
    J Antimicrob Chemother; 1986 May; 17 Suppl C():47-55. PubMed ID: 3722046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the combination of ticarcillin with clavulanic acid in renal insufficiency.
    Dalet F; Amado E; Cabrera E; Donate T; del Rio G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():57-64. PubMed ID: 3722047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.